Printer Friendly

COMPANY INFORMATION
ImmunoVaccine Inc. 303-1819 Granville St Halifax, NS B3J 3R1 Tel: (902) 492-1819 Fax: (902) 492-0888 Contact Name Brian Lowe Industry Biotechnology		Key Executives Randal Chase, CEO Develops infectious disease and therapeutic cancer vaccines.
FP ADVISOR COVERAGE ImmunoVaccine Inc. • FP Corporate Surveys • FP Directory of Directors • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/IMV $1.43 $2.25 $0.71 n.a. n.a. n.a. n.a. Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 31,841 n.a. $-0.60 Mar. 31/09 615.0% n.a. n.a. $64,084
ANNUAL FINANCIALS Periods ended: 12m Mar. 31/09 12m Mar. 31/08 $000s $000s Operating revenue 106 245 Net income (3,732) (2,564) Total assets 2,026 2,315 $ $ Earnings per share* (0.60) (0.45)   * Common

COMPANY NEWS

Results for 'ImmunoVaccine Inc.' from past 30 days: No hits. (Links are to articles.)